Detalhe da pesquisa
1.
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Lancet Oncol
; 25(3): 338-351, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423048
2.
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Lancet Oncol
; 25(3): 352-365, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423049
3.
Prognosis of cancer survivors: estimation based on differential equations.
Biostatistics
; 24(2): 345-357, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34557893
4.
Distribution and characteristics of malignant tumours by lung lobe.
BMC Pulm Med
; 24(1): 106, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439038
5.
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Int J Cancer
; 152(9): 1763-1777, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533660
6.
Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications.
Br J Cancer
; 129(5): 819-828, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433898
7.
Risk and survival in colorectal cancer with increasing body mass index: A nationwide population-based cohort study.
Colorectal Dis
; 25(3): 375-385, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222384
8.
Valorization for Biodiversity and Ecosystem Services in the Agri-Food Value Chain.
Environ Manage
; 72(6): 1163-1188, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495685
9.
Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort study.
HPB (Oxford)
; 25(11): 1382-1392, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544854
10.
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
Gut
; 71(8): 1532-1543, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824149
11.
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
Lancet Oncol
; 23(5): 587-600, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397210
12.
Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.
Br J Cancer
; 126(8): 1224-1228, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058590
13.
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Thorax
; 77(4): 378-390, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282033
14.
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
BMC Cancer
; 22(1): 220, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227226
15.
Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.
BMC Med Res Methodol
; 22(1): 2, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991487
16.
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Gut
; 70(2): 234-242, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554620
17.
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Gut
; 70(1): 114-126, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482683
18.
Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Int J Cancer
; 149(12): 2020-2031, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460109
19.
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
Int J Cancer
; 148(7): 1575-1585, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33006395
20.
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study.
Br J Cancer
; 124(5): 1026-1032, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293692